In the same way, overexpression of SRPK2 was observed in 87/107 (81%), 51/54 (94%) and 36/53 (68%) NSCLC, ADC and SCC respectively (Table 3; p<0.0001 versus normal). This evidence concerns the gene SRPK2 and non-small cell lung carcinoma.